Cargando…
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
In this study, it was aimed to investigate$^{149}$Tb-PSMA-617 for targeted α-therapy (TAT) using a mouse model of prostate-specific membrane antigen (PSMA)-expressing prostate cancer.$^{149}$Tb-PSMA-617 was prepared with >98% radiochemical purity (6 MBq/nmol) for the treatment of mice with PSMA-p...
| Autores principales: | , , , , , , , |
|---|---|
| Publicado: |
2019
|
| Acceso en línea: | https://dx.doi.org/10.1038/s41598-019-54150-w http://cds.cern.ch/record/2702959 |